Wildlife officers in Costa Rica’s Guanacaste Province identified eight free-ranging male white-nosed coatis with nodular or ulcerative cutaneous lesions between 2024 and 2026. The animals originated from seven distinct geographic locations across the province; one site yielded two affected coatis. All eight animals exhibited variable clinical deterioration and were referred to rehabilitation facilities. Several died shortly after admission. The study authors reported these findings as the first detection of Mycobacterium africanum in free-ranging wildlife in the Americas, and they mapped case locations against land-use layers to show diverse ecologic and anthropogenic settings.
Clinical presentations ranged from localized cutaneous masses and regional lymphadenitis to extensive ulcerative skin lesions, progressive pneumonia, and poor body condition. Six coatis underwent full necropsy; the other two were assessed through archived tissues. The necropsied animals all had nodular or ulcerative cutaneous lesions plus granulomatous pulmonary disease. Multifocal whitish nodules were present on pleura and lung surfaces, and lesions extended to the diaphragm, liver, spleen, intestine, and multiple lymph nodes.
Histopathology showed granulomatous inflammation dominated by histiocytes with variable neutrophils, lymphocytes, and multinucleated giant cells surrounding central caseous necrosis. Ziehl–Neelsen staining demonstrated abundant acid-fast bacilli in granulomas across multiple organs in all six necropsied coatis. One radiograph included in the report demonstrated well-defined soft-tissue masses in cervical and elbow regions and a mild, diffuse increase in pulmonary opacity.
Tissue samples (skin, lung, liver) were individually homogenized in sterile saline and decontaminated using a modified Petroff method. Total DNA extraction used commercial kits (Promega Maxwell system reported for some samples; QIAGEN DNeasy used for others after overnight proteinase K digestion), following manufacturer protocols. The laboratory inoculated sediments onto Löwenstein-Jensen solid medium and into MGIT liquid culture tubes, with Löwenstein-Jensen incubated up to 56 days and MGIT monitored for up to 42 days in the BACTEC MGIT 960 system. Cultures with no visible growth by these endpoints were classified as negative.
The team applied two real-time PCR approaches to detect MTBC DNA depending on reagent availability: the Anyplex MTB/NTM Real-Time Detection Kit or the Xpert MTB/RIF Ultra cartridge. For independent confirmation in four animals, they used separate PCR assays targeting insertion sequences IS1081 and IS6110. Controls included M. africanum ATCC 35711 and M. bovis NCTC 10772. The authors reported negative extraction and amplification controls in all molecular runs.
Speciation and typing of MTBC-positive samples used the GenoType MTBC assay. Drug-resistance screening employed GenoType MTBDRplus and MTBDRsl assays. To refine lineage assignment, investigators performed targeted next-generation sequencing (tNGS) with the Deeplex Myc-TB assay on a lung tissue sample (coati D7264-25). Libraries were sequenced with paired-end runs on an Illumina MiSeq and analyzed with Deeplex software.
Across these molecular methods, the team identified the infecting organism as Mycobacterium africanum, specifically lineage 6. Independent PCR-based detection validated MTBC DNA in tissue samples from four coatis processed in separate runs. The report did not present extensive sequence-level phylogenetic analysis beyond lineage assignment in the main text; any detailed genomic alignments or single-nucleotide variant lists were not described in the article body.
The detection of M. africanum lineage 6 in free-ranging white-nosed coatis expands the documented host range of this member of the MTBC beyond humans and previously reported sporadic domestic or wild animal infections. The authors framed these findings as evidence supporting wildlife surveillance as an early indicator prompting coordinated One Health investigation and response. They noted that M. africanum accounts for a substantial fraction of human tuberculosis in some West African regions but is rarely reported in the Americas, making these wildlife detections epidemiologically notable.
The paper did not report concurrent human TB screening results, contact tracing, or targeted testing of domestic animals in the affected areas. Therefore, no direct linkage to human cases or specific transmission pathways is documented in the source. The authors emphasized the potential broader host range and zoonotic questions raised by such findings.
The investigators acknowledged gaps that remain unresolved in the report. The article did not provide data on human or domestic-animal infections linked to these coati cases; it did not describe active epidemiologic tracing or environmental sampling in the reported localities. The study team did not report experimental infection data, nor did they present detailed phylogeographic analyses establishing the source or timing of introduction into Costa Rica. These specific transmission dynamics and the public health risk to humans or livestock therefore remain unanswered based on the data presented.
The findings call for coordinated follow-up surveillance, but the source did not specify an action plan or timeline for such investigations. Future targeted epidemiologic work, including human case finding, broader wildlife screening, and genomic comparisons with human and animal MTBC isolates, would be needed to clarify transmission routes and risk — tasks the present article documents as outstanding.